- Home
- LPTX vs COE Comparison
LPTX vs COE Comparison
Compare LPTX & COE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTX
- COE
- Stock Information
- Founded
- LPTX 2011
- COE 2011
- Country
- LPTX United States
- COE Singapore
- Employees
- LPTX N/A
- COE N/A
- Industry
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- COE Other Consumer Services
- Sector
- LPTX Health Care
- COE Real Estate
- Exchange
- LPTX Nasdaq
- COE Nasdaq
- Market Cap
- LPTX 119.6M
- COE 112.7M
- IPO Year
- LPTX N/A
- COE 2016
- Fundamental
- Price
- LPTX $0.38
- COE $19.80
- Analyst Decision
- LPTX Buy
- COE
- Analyst Count
- LPTX 2
- COE 0
- Target Price
- LPTX $8.00
- COE N/A
- AVG Volume (30 Days)
- LPTX 283.3K
- COE 6.2K
- Earning Date
- LPTX 05-13-2025
- COE 06-11-2025
- Dividend Yield
- LPTX N/A
- COE N/A
- EPS Growth
- LPTX N/A
- COE N/A
- EPS
- LPTX N/A
- COE N/A
- Revenue
- LPTX N/A
- COE $50,692,000.00
- Revenue This Year
- LPTX N/A
- COE N/A
- Revenue Next Year
- LPTX N/A
- COE N/A
- P/E Ratio
- LPTX N/A
- COE N/A
- Revenue Growth
- LPTX N/A
- COE 86.98
- 52 Week Low
- LPTX $0.22
- COE $6.65
- 52 Week High
- LPTX $4.79
- COE $25.70
- Technical
- Relative Strength Index (RSI)
- LPTX 48.68
- COE 58.42
- Support Level
- LPTX $0.35
- COE $17.90
- Resistance Level
- LPTX $0.40
- COE $19.89
- Average True Range (ATR)
- LPTX 0.04
- COE 0.62
- MACD
- LPTX 0.00
- COE 0.00
- Stochastic Oscillator
- LPTX 53.70
- COE 95.00
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is in developing targeted antibody therapies for cancer treatment, focusing on inhibiting tumor-promoting pathways, targeting cancer-specific cell surface molecules, and activating the immune system against cancer cells. The company's lead program, DKN-01, targets Dickkopf-related protein 1 (DKK1) and is in clinical trials for esophagogastric, gynecologic, and colorectal cancers. Their second program, FL-301, targets Claudin18.2-expressing cells. Additionally, the company has two preclinical antibody programs, FL-302 and FL-501, aimed at developing transformative cancer treatments. Operating as a single segment, the company's sole focus is on developing innovative drugs to address unmet needs in cancer therapy. .
About COE 51Talk Online Education Group
51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Group operates in seven principal geographical area: China, Hong Kong, Philippines, Singapore, Malaysia, Thailand and Saudi Arabia.